VYCOR MEDICAL, INC. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- VYCOR MEDICAL, INC. stock issued during period, value, issued for services for the quarter ending 2024-12-31 was $0.00.
- VYCOR MEDICAL, INC. stock issued during period, value, issued for services for the quarter ending 2024-09-30 was $73.26K.
- VYCOR MEDICAL, INC. stock issued during period, value, issued for services for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- VYCOR MEDICAL, INC. stock issued during period, value, issued for services for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- VYCOR MEDICAL, INC. stock issued during period, value, issued for services for fiscal 2024 was $73.26K, a 674.88% increase from fiscal 2023.
- VYCOR MEDICAL, INC. stock issued during period, value, issued for services for fiscal 2023 was $9.45K, a 94.85% decline from fiscal 2022.
- VYCOR MEDICAL, INC. stock issued during period, value, issued for services for fiscal 2022 was $183.63K, a 43.52% decline from fiscal 2021.
- VYCOR MEDICAL, INC. stock issued during period, value, issued for services for fiscal 2021 was $325.13K.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $73.26K 10-K · filed 2026-03-31 |
| 2024-09-30 | $73.26K 10-Q · filed 2025-11-14 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $9.45K 10-K · filed 2025-04-15 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | |
| 2023-06-30 | $9.45K 10-Q · filed 2024-08-13 | |
| 2022-12-31 | $7.38K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $183.63K 10-K · filed 2024-04-16 |
| 2022-09-30 | $56.79K 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $86.13K 10-Q · filed 2023-08-11 | |
| 2022-03-31 | $45.54K 10-Q · filed 2023-05-12 | |
| 2021-12-31 | $325.13K 10-K · filed 2023-04-14 | |
| 2015-12-31 | 249.49K EUR 10-K · filed 2016-03-30 | |
| 2015-06-30 | $50.31K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14 | |
| 2015-03-31 | $63.14K 10-Q · filed 2015-05-15 |